Monday, October 28, 2024

Health

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the watchdog says.

No comments:

Post a Comment

Random Posts

SoraBook

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum rhoncus vehicula tortor, vel cursus elit. Donec nec nisl felis. Pellentesque ultrices sem sit amet eros interdum, id elementum nisi ermentum.Vestibulum rhoncus vehicula tortor, vel cursus elit. Donec nec nisl felis. Pellentesque ultrices sem sit amet eros interdum, id elementum nisi fermentum.




Comments

Contact Form

Name

Email *

Message *